It’s Not "Just Hives": Advancing Targeted Care in Chronic Spontaneous Urticaria
Please visit answersincme.com/2026-MC-001884-replay860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Marc Serota, MD; Kristin Sokol, MD, MS, MPH; and Michelle Tarbox, MD. In this activity, experts in chronic spontaneous urticaria (CSU) discuss strategies to reduce diagnostic delays and how to personalize care beyond antihistamines. Upon completion of this activity, participants should be better able to: Recognize the impact of delayed diagnosis on disease control in patients with CSU; Review key inflammatory pathways—including type 2 inflammation—in CSU pathogenesis and how targeted therapies modulate them; Assess the latest clinical data for targeted therapies for the treatment of CSU; and Apply evidence-based strategies to personalize the management of antihistamine-refractory CSU.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from CME in Minutes: Education in Primary Care
From Evidence to Impact: Leveraging the Latest Data to Elevate Standards and Patient Outcomes in mHSPC
Management of Overactive Bladder in Patients With Benign Prostatic Hyperplasia: Tailoring Treatment for Individualized Care
Translating Evidence Into Practice: Optimizing Chemotherapy-Free Intervals and Sequencing in mCRC
Oncology - Pathology Dialogues: Evolving Diagnostic Pathways to Expand Treatment of Extrapulmonary Neuroendocrine Neoplasms
Get summaries like this every morning.
Free AI-powered recaps of CME in Minutes: Education in Primary Care and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.